Table of Contents

Selecta Biosciences

Selecta Biosciences, Inc. is an American biotechnology company based in Watertown, Massachusetts. It trades on the NASDAQ under the ticker name SELB.1)

History

Selecta Biosciences was founded in 2008 by Omid Farokhzad, after its incorporation in 2007.2) 3) The company was founded to develop immunomodulatory nanoparticles for the treatment and prevention of human diseases. Early investors in the then-private startup included Polaris Partners and Flagship Pioneering, the latter of which would soon also launch Moderna.4) 5) They were joined in February 2009 by additional investments from NanoDimension and Professor Timothy Springer (a founding investor in Moderna).6)

In December 2021, Selecta invested in a Series B funding round for Cyrus Biotechnology.7)

Activities

The company has had license and collaboration agreements with:8) 9)

Patents

Number Title Date filed Inventor(s)
WO2012149411 CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS April 27, 2012 David Altreuter, Aaron Griset, Roberto Maldonaldo

Organization

Personnel10)
Name Position Notes
Carsten Brunn President and CEO Bayer, European Federation of Pharmaceutical Industries and Associations Japan, Eli Lilly, Novartis, Basilea Pharmaceuticals, Bausch & Lomb, Surface Oncology
Lloyd Johnston Chief Operations Officer Alkermes, Advanced Inhalation Research (AIR), University of New South Wales
Takeshi Kei Kishimoto Chief Science Officer Momenta Pharmaceuticals, Millennium Pharmaceuticals, Boehringer Ingelheim
Kristen Baldwin Chief People Officer LIVEKINDLY Collective, CEO.works, Bayer, Otsuka Pharmaceuticals
Peter Traber Chief Medical Officer Alacrita Consulting, Morphic Therapeutic, Galectin Therapeutics, GlaxoSmithKline, Baylor College of Medicine, University of Pennsylvania Health System, University of Pennsylvania, Caladrius Biosciences
Blaine Davis Chief Financial Officer Protera Therapeutics, Insmed, Endo International, Endo Ventures, Bristol-Myers Squibb
Matthew Bartholomae General Counsel, Secretary Minerva Neurosciences
Ann Donohue Vice President of Finance & Controller -
Ulrich von Andrian Co-Founder and Co-Chair of the Scientific Advisory Board -
Carrie Cox Chairman Humacyte, Schering-Plough, Pharmacia & Upjohn, Texas Instruments, Cardinal Health, Organon, Celgene, Array BioPharma, electroCore, Prism Pharmaceutical
Timothy Barabe Director ArQule, Veeva Systems, Vigilant Biosciences, Affymetrix, Human Genome Sciences, Regent Medical, Sandoz
Nishan de Silva Director AFYX Therapeutics, Poseida Therapeutics, Ligand Pharmaceuticals, Warburg Pincus, McKinsey & Company
Scott Myers Director AMAG Pharmaceuticals, Rainier Therapeutics, Cascadian Therapeutics, Aerocrine, UCB, Johnson & Johnson, Trillium Therapeutics, Harpoon Therapeutics, Dynavax
Aymeric Sallin Director NanoDimension, H55, Crocus Technology, Tarveda Therapeutics, Swiss Academy of Engineering Science, École Polytechnique Fédérale de Lausanne (EPFL)
Timothy Springer Director Harvard Medical School, Boston Children's Hospital, LeukoSite, National Academy of Sciences
Patrick Zenner Director Roche, ArQule, West Pharmaceutical Services
Shuang Sarah Wu Senior Manager of Strategy and Business Development (former)11) 12) Now at Pfizer

Investors

Companies that have invested in/provided funding for Selecta include:13) 14) 15)

1)
Selecta Biosciences Inc (SELB) Stock Price & News. Google Finance. Retrieved February 3, 2023, from https://www.google.com/finance/quote/SELB:NASDAQ
2)
Selecta Biosciences - Crunchbase Company Profile & Funding. Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences
3) , 8)
Selecta Biosciences, Inc. (SELB) Company Profile & Facts. Yahoo Finance. Retrieved October 16, 2021, from https://web.archive.org/web/20211016161609/https://finance.yahoo.com/quote/SELB/profile?p=SELB
4)
Bratzler, R. (2009, February 25). Selecta Biosciences, Inc. Closes $15.1M Series B Financing. Flagship Pioneering. http://archive.today/2023.02.03-174945/https://www.flagshippioneering.com/press/selecta-biosciences-inc-closes-151m-series-b-financing
5)
Moderna. Flagship Pioneering. Retrieved September 15, 2022, from http://archive.today/2022.09.15-150329/https://www.flagshippioneering.com/companies/moderna
6)
Tognini, G. (2020, May 16). Exclusive: Meet The Harvard Professor Who Became A Billionaire Thanks To Coronavirus. Forbes. https://web.archive.org/web/20230203175707/https://www.forbes.com/sites/giacomotognini/2020/05/16/exclusive-harvard-professor-who-became-a-billionaire-thanks-to-moderna-talks-about-his-investing/?sh=5ac096b6b8d7
7) , 15)
Selecta Biosciences - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved February 3, 2023, from https://www.crunchbase.com/organization/selecta-biosciences/company_financials
9)
Partnerships. Selecta Biosciences. Retrieved October 13, 2022, from https://web.archive.org/web/20221013150325/https://selectabio.com/partnerships/
10)
About Us. Selecta Biosciences. Retrieved February 4, 2023, from https://archive.ph/Ntfgo
11)
SHUANG (SARAH) WU, Gerente Senior, Estrategia y Desarrollo de Negocios, Selecta Biosciences. GetEmail.io. Retrieved February 3, 2023, from https://web.archive.org/web/20230203004058/https://b2b.getemail.io/shuang-sarah-wu-pfizer-person-company-21927493-3411511.html
12)
NOSTUPID3. (2023, January 31). 微博. Weibo. https://archive.ph/WPywO
13)
Selecta Biosciences, Inc. (SELB) Stock Major Holders. Yahoo Finance. Retrieved February 3, 2023, from https://finance.yahoo.com/quote/SELB/holders?p=SELB
14)
Companies. Flagship Pioneering. Retrieved January 15, 2023, from https://web.archive.org/web/20230115044601/https://www.flagshippioneering.com/companies